Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
APGE	APOGEE THERAPEUTICS INC	$4.59B	-36.80%	-34.90%	-28.11%	-43.00%	0.04	26.57	N/A	N/A	N/A
CTNM	CONTINEUM THERAPEUTICS INC	$455.87M	-30.10%	-28.30%	-22.47%	-35.30%	0.06	27.50	N/A	N/A	N/A
ARTV	ARTIVA BIOTHERAPEUTICS INC	$131.49M	-60.20%	-52.40%	-71.16%	-63.30%	0.19	8.61	N/A	N/A	N/A
PRAX	PRAXIS PRECISION MEDICINES INC	$8.31B	-58.70%	-53.50%	-34.54%	-98.00%	0.07	10.22	N/A	N/A	N/A
COGT	COGENT BIOSCIENCES INC	$5.42B	-100.20%	-68.50%	-37.30%	-94.90%	0.47	14.24	N/A	N/A	N/A
CRSP	CRISPR THERAPEUTICS AG	$4.44B	-31.50%	-26.70%	-27.31%	-29.00%	0.18	13.32	100.00%	-16,569.80%	-16,466.24%
ELDN	ELEDON PHARMACEUTICALS INC	$218.45M	-64.90%	-30.20%	-30.25%	-35.60%	0.40	7.40	N/A	N/A	N/A
CVKD	CADRENAL THERAPEUTICS INC	$13.53M	-279.50%	-204.50%	-525.99%	928.40%	0.50	3.02	N/A	N/A	N/A
DMAC	DIAMEDICA THERAPEUTICS INC	$352.04M	-83.30%	-73.60%	-61.70%	-90.10%	0.11	10.67	N/A	N/A	N/A
SRRK	SCHOLAR ROCK HOLDING CORP	$5.13B	-145.90%	-96.70%	-106.36%	-188.30%	0.65	6.95	N/A	N/A	N/A
CATX	PERSPECTIVE THERAPEUTICS INC	$507.00M	-41.30%	-34.30%	-43.45%	-50.50%	0.29	5.17	100.00%	-11,665.30%	-11,712.44%
ATAI	ATAIBECKLEY INC	$1.27B	-389.70%	-287.70%	-244.61%	-421.50%	0.32	11.74	100.00%	-16,142.00%	-16,106.31%
CELC	CELCUITY INC	$4.91B	-179.00%	-58.00%	-33.96%	-41.30%	3.07	12.26	N/A	N/A	N/A
NMRA	NEUMORA THERAPEUTICS INC	$419.39M	-113.80%	-96.90%	-154.89%	-242.80%	0.35	6.85	N/A	N/A	N/A
GNPX	GENPREX INC	$4.27M	-891.70%	-389.10%	-1,658.99%	-18,136.00%	3.64	0.67	N/A	N/A	N/A
NGNE	NEUROGENE INC	$295.08M	-29.80%	-27.50%	-31.17%	-38.50%	0.08	18.39	N/A	N/A	N/A
BCTX	BRIACELL THERAPEUTICS CORP	$30.31M	-174.50%	-140.80%	-99.17%	-849.10%	0.11	10.10	N/A	N/A	N/A
AVIR	ATEA PHARMACEUTICALS INC	$450.94M	-46.30%	-42.50%	-59.73%	-65.00%	0.14	7.82	N/A	N/A	N/A
CTMX	CYTOMX THERAPEUTICS INC	$757.33M	-23.20%	-14.00%	-19.18%	-29.00%	0.53	3.09	100.00%	-26.70%	-26.42%
SRTS	SENSUS HEALTHCARE INC	$63.71M	-15.10%	-13.40%	-19.92%	-32.00%	0.10	9.72	43.20%	-28.10%	-35.02%
BNTX	BIONTECH SE	$21.42B	-6.00%	-5.30%	-4.94%	-11.00%	0.14	7.54	77.60%	-39.60%	-34.18%
EPRX	EUPRAXIA PHARMACEUTICALS INC	$368.77M	-69.20%	-66.80%	-47.92%	-20,841.50%	0.07	15.12	N/A	N/A	N/A
CVRX	CVRX INC	$228.65M	-99.30%	-45.80%	-51.92%	-71.80%	1.67	7.63	85.30%	-94.10%	-83.84%
BMEA	BIOMEA FUSION INC	$80.60M	-310.10%	-145.40%	-241.56%	-1,835.00%	2.53	3.18	N/A	N/A	N/A
ENTX	ENTERA BIO LTD	$50.90M	-71.90%	-63.40%	-67.99%	2,206.40%	0.14	10.83	0.00%	-8,694.40%	-8,683.06%
PASG	PASSAGE BIO INC	$23.83M	-135.00%	-60.40%	-116.13%	-188.10%	2.32	2.07	N/A	N/A	N/A
MNPR	MONOPAR THERAPEUTICS	$368.95M	-25.70%	-24.80%	-13.73%	-155.60%	0.02	56.10	N/A	N/A	N/A
SENS	SENSEONICS HOLDINGS INC	$270.67M	-102.70%	-54.90%	-62.95%	-57.30%	1.07	4.83	44.70%	-196.00%	-181.98%
DFTX	DEFINIUM THERAPEUTICS INC	$1.83B	-84.40%	-60.40%	-47.75%	-103.80%	0.32	6.29	N/A	N/A	N/A
BCAX	BICARA THERAPEUTICS INC	$1.01B	-27.20%	-26.00%	-30.02%	-205.00%	0.05	14.14	N/A	N/A	N/A
CLYM	CLIMB BIO INC	$291.86M	-33.40%	-32.20%	-37.23%	-39.40%	0.05	15.16	N/A	N/A	N/A
SANA	SANA BIOTECHNOLOGY INC	$829.96M	-142.00%	-58.90%	-72.20%	-148.50%	1.59	1.89	N/A	N/A	N/A
ARMP	ARMATA PHARMACEUTICALS INC	$304.81M	N/A	-54.50%	63.18%	-29.50%	-1.94	0.12	100.00%	-3,797.70%	-2,580.16%
KOD	KODIAK SCIENCES INC	$1.18B	-246.20%	-78.40%	-123.74%	-76.50%	8.20	1.79	N/A	N/A	N/A
TECX	TECTONIC THERAPEUTIC INC	$561.05M	-26.90%	-25.80%	-28.98%	3,727.70%	0.04	26.63	N/A	N/A	N/A
MSLE	SATELLOS BIOSCIENCE INC	$106.37M	N/A	N/A	N/A	N/A	0.07	14.84	N/A	N/A	N/A
MAIA	MAIA BIOTECHNOLOGY INC	$54.07M	-715.10%	-199.20%	-1,249.70%	434.20%	281.75	1.18	N/A	N/A	N/A
RVPH	REVIVA PHARMACEUTICALS HOLDINGS INC	$4.60M	-20,541.50%	-187.50%	-494.36%	222.10%	2.15	1.39	N/A	N/A	N/A
MCRB	SERES THERAPEUTICS INC	$81.48M	13.30%	3.90%	4.79%	3.80%	2.13	2.56	100.00%	721.90%	721.93%
ACRV	ACRIVON THERAPEUTICS INC	$64.32M	-57.20%	-51.10%	-68.31%	-76.70%	0.15	7.69	N/A	N/A	N/A
GANX	GAIN THERAPEUTICS INC	$70.39M	-341.30%	-174.10%	-266.08%	1,085.50%	0.86	2.52	N/A	N/A	N/A
RVMD	REVOLUTION MEDICINES INC	$18.98B	-63.10%	-48.10%	-53.63%	-53.70%	0.44	7.15	N/A	N/A	N/A
XENE	XENON PHARMACEUTICALS INC	$4.57B	-55.80%	-52.00%	-58.32%	-69.30%	0.09	13.42	100.00%	-4,612.10%	-4,598.59%
RADX	RADIOPHARM THERANOSTICS LTD	$34.02M	-99.40%	-45.70%	-50.41%	-149.70%	0.97	2.67	1.10%	-997.40%	-992.74%
IRON	DISC MEDICINE INC	$2.22B	-32.80%	-30.20%	-27.03%	-35.40%	0.09	21.94	N/A	N/A	N/A
VANI	VIVANI MEDICAL INC	$84.62M	-293.60%	-79.50%	-142.87%	-80.80%	18.13	0.61	N/A	N/A	N/A
ELAB	PMGC HOLDINGS INC	$109.14k	-82.90%	-63.50%	-70.06%	-523.90%	0.76	1.79	82.20%	458.40%	454.25%
IONS	IONIS PHARMACEUTICALS INC	$11.73B	-68.90%	-12.30%	-10.54%	-7.90%	6.21	3.83	98.30%	-40.40%	-30.63%
BHVN	BIOHAVEN LTD	$1.34B	-688.90%	-158.00%	-219.78%	-196.70%	7.67	3.18	N/A	N/A	N/A
AUTL	AUTOLUS THERAPEUTICS PLC	$364.62M	-63.80%	-30.90%	-40.97%	-28.80%	1.49	6.19	-61.20%	-439.70%	-463.91%
TYRA	TYRA BIOSCIENCES INC	$2.00B	-41.20%	-38.40%	-45.35%	-55.20%	0.09	14.67	N/A	N/A	N/A
CALC	CALCIMEDICA INC	$9.10M	-1,172.90%	-162.10%	-286.88%	-194.80%	-3.05	3.58	N/A	N/A	N/A
IKT	INHIBIKASE THERAPEUTICS INC	$135.32M	-57.20%	-52.80%	-65.37%	-217.00%	0.09	11.73	N/A	N/A	N/A
NRIX	NURIX THERAPEUTICS INC	$1.48B	-57.50%	-43.80%	-43.83%	-59.10%	0.28	7.02	100.00%	-314.90%	-314.00%
ACHV	ACHIEVE LIFE SCIENCES INC	$212.94M	-196.70%	-118.30%	-121.91%	-306.00%	0.55	5.14	N/A	N/A	N/A
PROK	PROKIDNEY CORP	$582.70M	N/A	-18.80%	-22.49%	-28.20%	-0.03	9.13	100.00%	-7,725.20%	-7,678.39%
SNDA	SONIDA SENIOR LIVING INC	$1.51B	-210.50%	-9.10%	-4.30%	-2.30%	-71,690.00	0.74	21.80%	-20.00%	-8.35%
MOH	MOLINA HEALTHCARE INC	$7.18B	11.00%	3.00%	9.53%	14.50%	2.83	1.69	9.00%	1.00%	1.72%
VRDN	VIRIDIAN THERAPEUTICS INC	$2.76B	-58.40%	-50.40%	-40.74%	-66.10%	0.25	12.65	100.00%	-483.60%	-476.58%
RCEL	AVITA MEDICAL INC	$121.00M	N/A	-78.40%	693.27%	-122.80%	-4.39	0.57	82.10%	-67.80%	-60.85%
PMN	PROMIS NEUROSCIENCES INC	$37.88M	-336.90%	-184.40%	-316.68%	1,845.00%	1.34	1.76	N/A	N/A	N/A
OLMA	OLEMA PHARMACEUTICALS INC	$1.23B	-42.90%	-38.70%	-33.73%	-48.00%	0.12	9.95	N/A	N/A	N/A
HOWL	WEREWOLF THERAPEUTICS INC	$38.15M	-144.40%	-71.70%	-109.10%	-184.00%	1.69	3.87	N/A	N/A	N/A
PRCT	PROCEPT BIOROBOTICS CORP	$1.45B	-25.10%	-18.60%	-23.48%	-43.90%	0.39	6.85	63.70%	-31.00%	-33.71%
ARVN	ARVINAS INC	$699.73M	-14.30%	-9.30%	-13.99%	-13.40%	0.66	4.92	100.00%	-30.80%	-30.65%
LITS	LITE STRATEGY INC	$42.54M	-68.90%	-67.50%	-48.50%	-91.70%	0.01	10.04	N/A	N/A	N/A
CRDL	CARDIOL THERAPEUTICS INC	$80.98M	-218.50%	-154.20%	-360.16%	733.30%	0.35	3.89	N/A	N/A	N/A
ZBIO	ZENAS BIOPHARMA INC	$1.28B	-157.00%	-113.40%	-115.42%	-227.10%	0.58	5.61	100.00%	-3,777.40%	-3,704.89%
ONCY	ONCOLYTICS BIOTECH INC	$98.45M	-755.20%	-188.30%	-478.42%	2,290.60%	129.93	1.84	N/A	N/A	N/A
MGTX	MEIRAGTX HOLDINGS PLC	$579.53M	-1,065.50%	-76.50%	-427.19%	-93.50%	-5.67	0.22	41.00%	-615.30%	-569.48%
PCVX	VAXCYTE INC	$7.88B	-25.90%	-23.80%	-27.41%	-26.70%	0.12	7.91	N/A	N/A	N/A
TMCI	TREACE MEDICAL CONCEPTS INC	$80.09M	-62.20%	-29.50%	-33.56%	-26.80%	1.18	4.31	79.80%	-27.70%	-25.24%
MBOT	MICROBOT MEDICAL INC	$170.58M	-37.10%	-34.40%	-16.58%	-41.60%	0.05	27.53	N/A	N/A	N/A
WVE	WAVE LIFE SCIENCES LTD	$2.21B	-85.70%	-57.50%	-37.61%	800.30%	0.22	6.47	100.00%	-478.30%	-478.33%
VERA	VERA THERAPEUTICS INC	$2.89B	-59.70%	-49.10%	-42.87%	-56.70%	0.22	13.64	N/A	N/A	N/A
QNRX	QUOIN PHARMACEUTICALS LTD	$11.66M	-334.40%	-125.20%	-2,088.80%	-453.90%	-6.29	1.04	N/A	N/A	N/A
RGNX	REGENXBIO INC	$418.07M	-103.10%	-37.80%	-44.45%	-27.00%	3.41	2.38	88.10%	-113.80%	-87.34%
AVTX	AVALO THERAPEUTICS INC	$243.36M	-88.40%	-73.90%	-86.18%	-288.20%	0.37	14.28	54.70%	-52,019.80%	-52,575.52%
SNGX	SOLIGENIX INC	$12.10M	-267.10%	-135.70%	-149.12%	441.10%	0.49	3.18	N/A	N/A	N/A
JSPR	JASPER THERAPEUTICS INC	$34.42M	-261.90%	-150.80%	-249.87%	1,140.10%	3.97	2.59	N/A	N/A	N/A
FULC	FULCRUM THERAPEUTICS INC	$450.88M	-30.20%	-28.50%	-21.20%	-42.40%	0.05	27.40	N/A	N/A	N/A
OSUR	ORASURE TECHNOLOGIES INC	$203.92M	-18.60%	-15.90%	-18.42%	-53.50%	0.18	6.58	41.90%	-59.80%	-58.19%
RXST	RXSIGHT INC	$265.76M	-14.00%	-12.50%	-13.61%	-14.40%	0.13	10.95	76.60%	-29.00%	-28.90%
ACET	ADICET BIO INC	$66.41M	-83.00%	-68.00%	-68.36%	-87.70%	0.21	7.47	N/A	N/A	N/A
ACB	AURORA CANNABIS INC	$184.87M	-20.60%	-14.00%	-15.21%	-17.60%	0.39	3.06	34.50%	-30.20%	-25.65%
CABA	CABALETTA BIO INC	$283.02M	-107.10%	-82.90%	-108.54%	-298.40%	0.36	3.60	N/A	N/A	N/A
ASBP	ASPIRE BIOPHARMA HOLDINGS INC	$1.93M	N/A	-1,490.10%	158.11%	923.80%	-1.21	0.17	45.50%	-1,056,755.00%	-933,320.14%
RZLT	REZOLUTE INC	$238.29M	-64.80%	-59.40%	-65.24%	-83.90%	0.08	14.18	N/A	N/A	N/A
SMMT	SUMMIT THERAPEUTICS INC	$12.03B	-296.80%	-251.00%	-159.19%	-794.50%	0.14	9.87	N/A	N/A	N/A
CMPS	COMPASS PATHWAYS PLC	$519.45M	-172.50%	-87.70%	-398.09%	-1,036.90%	5.80	1.23	N/A	N/A	N/A
MDWD	MEDIWOUND LTD	$217.68M	-65.80%	-30.20%	-35.10%	-60.20%	0.98	2.33	19.20%	-140.80%	-125.30%
KURA	KURA ONCOLOGY INC	$729.60M	-102.60%	-39.60%	-44.55%	-53.20%	3.24	6.06	99.90%	-412.90%	-410.27%
SNTI	SENTI BIOSCIENCES INC	$24.19M	-197.70%	-63.10%	-117.03%	-75.10%	5.49	1.51	N/A	N/A	N/A
ABSI	ABSCI CORP	$445.10M	-60.20%	-50.90%	-52.98%	-103.30%	0.17	5.89	100.00%	-4,071.20%	-4,051.97%
MDCX	MEDICUS PHARMA LTD	$11.21M	-1,810.20%	-415.30%	4,357.13%	2,167.00%	-11.85	0.92	N/A	N/A	N/A
MDAI	SPECTRAL AI INC	$47.26M	N/A	-102.10%	3,348.60%	1,183.90%	-2.87	0.85	45.00%	-70.60%	-67.21%
AARD	AARDVARK THERAPEUTICS INC	$88.62M	-54.90%	-37.90%	-39.82%	-58.70%	0.09	12.04	N/A	N/A	N/A
PHGE	BIOMX INC	$7.79M	-274.00%	-125.20%	5,947.65%	-207.00%	-5.44	0.87	N/A	N/A	N/A
ATOS	ATOSSA THERAPEUTICS INC	$45.90M	-49.40%	-44.80%	-60.62%	5,857.40%	0.17	6.77	N/A	N/A	N/A
TARA	PROTARA THERAPEUTICS INC	$281.78M	-36.40%	-33.80%	-28.93%	-48.70%	0.07	14.58	N/A	N/A	N/A

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	605	-1.90%	-2.36%	-5.17%	-47.00%	27.63x	4.60x	-26.81%	-12.18%	-7.15%	+72.91%	Strong Buy
Diagnostics & Research	56	-0.25%	+1.44%	-8.39%	+4.52%	16.77x	3.64x	-2.51%	+6.45%	+12.69%	+30.99%	Strong Buy
Drug Manufacturers - General	20	-1.22%	-5.21%	-8.51%	+12.82%	31.77x	6.73x	+9.66%	+12.42%	+21.29%	+21.28%	Buy
Drug Manufacturers - Specialty & Generic	75	-1.41%	+0.09%	-10.27%	-31.55%	-156.26x	1.58x	+9.54%	+2.78%	+7.54%	+47.18%	Strong Buy
Healthcare Plans	10	-0.67%	-1.65%	-9.43%	-36.50%	22.32x	1.77x	+9.09%	+2.85%	+6.96%	+29.27%	Buy
Health Information Services	55	-2.28%	-0.80%	-7.61%	-85.38%	20.84x	2.84x	-8.77%	+2.34%	+4.53%	+60.56%	Buy
Medical Care Facilities	50	-1.19%	-4.99%	-9.99%	-51.10%	18.67x	5.40x	-69.03%	+7.60%	+15.96%	+22.23%	Buy
Medical Devices	137	-1.04%	-0.41%	-9.14%	-68.25%	25.74x	3.34x	+8.92%	+5.52%	+10.27%	+53.64%	Strong Buy
Medical Distribution	10	-1.41%	-5.68%	-7.36%	+30.14%	29.64x	308.26x	-99.48%	+3.28%	+23.36%	+11.91%	Strong Buy
Medical Instruments & Supplies	57	-1.30%	-1.16%	-9.50%	-13.90%	-443.62x	3.39x	+9.61%	+7.68%	+4.24%	+33.75%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Mar 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Bioventus (NASDAQ:BVS)

Bioventus (NASDAQ:BVS) is the #1 top healthcare stock out of 1075 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Bioventus (NASDAQ:BVS) is: Value: A, Growth: A, Momentum: C, Sentiment: C, Safety: B, Financials: A, and AI: C.

Bioventus (NASDAQ:BVS) has a Due Diligence Score of 47, which is 20 points higher than the healthcare sector average of 27. It passed 15 out of 33 due diligence checks and has strong fundamentals. Bioventus has seen its stock lose -11.29% over the past year, overperforming other healthcare stocks by 34 percentage points.

Bioventus has an average 1 year price target of $15.00, an upside of 73.61% from Bioventus's current stock price of $8.64.

Bioventus stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Bioventus, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Amneal Pharmaceuticals (NASDAQ:AMRX)

Amneal Pharmaceuticals (NASDAQ:AMRX) is the #2 top healthcare stock out of 1075 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Amneal Pharmaceuticals (NASDAQ:AMRX) is: Value: B, Growth: A, Momentum: B, Sentiment: B, Safety: C, Financials: C, and AI: C.

Amneal Pharmaceuticals (NASDAQ:AMRX) has a Due Diligence Score of 35, which is 8 points higher than the healthcare sector average of 27. It passed 11 out of 33 due diligence checks and has average fundamentals. Amneal Pharmaceuticals has seen its stock return 31.3% over the past year, overperforming other healthcare stocks by 77 percentage points.

Amneal Pharmaceuticals has an average 1 year price target of $15.00, an upside of 26.8% from Amneal Pharmaceuticals's current stock price of $11.83.

Amneal Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Amneal Pharmaceuticals, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Aveanna Healthcare Holdings (NASDAQ:AVAH)

Aveanna Healthcare Holdings (NASDAQ:AVAH) is the #3 top healthcare stock out of 1075 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Aveanna Healthcare Holdings (NASDAQ:AVAH) is: Value: B, Growth: B, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: C.

Aveanna Healthcare Holdings (NASDAQ:AVAH) has a Due Diligence Score of 32, which is 5 points higher than the healthcare sector average of 27. It passed 11 out of 33 due diligence checks and has average fundamentals. Aveanna Healthcare Holdings has seen its stock return 19.41% over the past year, overperforming other healthcare stocks by 65 percentage points.

Aveanna Healthcare Holdings has an average 1 year price target of $10.58, an upside of 62.32% from Aveanna Healthcare Holdings's current stock price of $6.52.

Aveanna Healthcare Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Aveanna Healthcare Holdings, 33.33% have issued a Strong Buy rating, 16.67% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 71 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Kamada (NASDAQ:KMDA)

Kamada (NASDAQ:KMDA) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 6.84%.

Kamada's dividend payout ratio of 57.1% indicates that its dividend yield is sustainable for the long-term.

2. Novabay Pharmaceuticals (NYSEMKT:NBY)

Novabay Pharmaceuticals (NYSEMKT:NBY) has an annual dividend yield of 344.83%, which is 338 percentage points higher than the healthcare sector average of 6.84%.

Novabay Pharmaceuticals's dividend payout ratio of -105.3% indicates that its high dividend yield might not be sustainable for the long-term.

3. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 23.25%, which is 16 percentage points higher than the healthcare sector average of 6.84%.

Dominari Holdings's dividend payout ratio of 8.4% indicates that its high dividend yield is sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -1.33% in the last day, and down -1.91% over the last week. Milestone Pharmaceuticals was the among the top losers in the healthcare sector, dropping -20% yesterday.

Milestone Pharmaceuticals shares are trading lower. The company reported its Q4 financial results.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 86, which is 69 points higher than the healthcare sector average of 17. It passed 6 out of 7 valuation due diligence checks.

Embecta's stock has dropped -32.8% in the past year. It has overperformed other stocks in the healthcare sector by 13 percentage points.

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 57, which is 40 points higher than the healthcare sector average of 17. It passed 4 out of 7 valuation due diligence checks.

Ironwood Pharmaceuticals's stock has gained 98.69% in the past year. It has overperformed other stocks in the healthcare sector by 144 percentage points.

3. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 54 points higher than the healthcare sector average of 17. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -20.57% in the past year. It has overperformed other stocks in the healthcare sector by 25 percentage points.

Are healthcare stocks a good buy now?

58.57% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 48.08% over the next year.

5.24% of healthcare stocks have a Zen Rating of A (Strong Buy), 12.55% of healthcare stocks are rated B (Buy), 50.55% are rated C (Hold), 23.75% are rated D (Sell), and 7.92% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is -5.68x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bioventus (NASDAQ:BVS)

2. Amneal Pharmaceuticals (NASDAQ:AMRX)

3. Aveanna Healthcare Holdings (NASDAQ:AVAH)

1. Kamada (NASDAQ:KMDA)

2. Novabay Pharmaceuticals (NYSEMKT:NBY)

3. Dominari Holdings (NASDAQ:DOMH)

1. Embecta (NASDAQ:EMBC)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Harmony Biosciences Holdings (NASDAQ:HRMY)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2026)Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bioventus (NASDAQ:BVS)

2. Amneal Pharmaceuticals (NASDAQ:AMRX)

3. Aveanna Healthcare Holdings (NASDAQ:AVAH)

1. Kamada (NASDAQ:KMDA)

2. Novabay Pharmaceuticals (NYSEMKT:NBY)

3. Dominari Holdings (NASDAQ:DOMH)

1. Embecta (NASDAQ:EMBC)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Harmony Biosciences Holdings (NASDAQ:HRMY)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.